ACTR-34. INTEGRATED CLINICAL EXPERIENCE WITH ONC201 IN PREVIOUSLY-TREATED H3 K27M-MUTANT GLIOMA PATIENTS

Andrew Chi; Isabel Arrillaga-Romany; Sharon Gardner; Patrick Wen; Tracy Batchelor; Matthew Hall; Yazmin Odia; Soumen Khatua; Wafik Zaky; Susan McGovern; Rebecca Harrison; John de Groot; Ashley Sumrall; Nicole Shonka; Zaid Khatib; Matthias Karajannis; Sabine Mueller; Rohinton Tarapore; Krystal Merdinger; Lee Schalop; Joshua Allen; Wolfgang Oster; Minesh P Mehta

doi:10.1093/neuonc/noy148.067

ACTR-34. INTEGRATED CLINICAL EXPERIENCE WITH ONC201 IN PREVIOUSLY-TREATED H3 K27M-MUTANT GLIOMA PATIENTS

Andrew Chi, Isabel Arrillaga-Romany, Sharon Gardner, Patrick Wen, Tracy Batchelor, Matthew Hall, Yazmin Odia, Soumen Khatua, Wafik Zaky, Susan McGovern, Rebecca Harrison, John de Groot, Ashley Sumrall, Nicole Shonka, Zaid Khatib, Matthias Karajannis, Sabine Mueller, Rohinton Tarapore, Krystal Merdinger, Lee SchalopJoshua Allen, Wolfgang Oster, Minesh P Mehta

Miami Cancer Institute

Research output: Contribution to conference › Presentation

Original language	American English
DOIs	https://doi.org/10.1093/neuonc/noy148.067
State	Published - Nov 5 2018
Event	Society for NeuroOncology (SNO) 23th Annual Meeting and Education Day - New Orleans, LA Duration: Nov 5 2018 → …

Conference

Conference	Society for NeuroOncology (SNO) 23th Annual Meeting and Education Day
Period	11/5/18 → …

Disciplines

Medicine and Health Sciences
Neoplasms
Neurology
Oncology

Access to Document

10.1093/neuonc/noy148.067License: Unspecified

Cite this

Chi, A., Arrillaga-Romany, I., Gardner, S., Wen, P., Batchelor, T., Hall, M., Odia, Y., Khatua, S., Zaky, W., McGovern, S., Harrison, R., de Groot, J., Sumrall, A., Shonka, N., Khatib, Z., Karajannis, M., Mueller, S., Tarapore, R., Merdinger, K., ... Mehta, M. P. (2018). ACTR-34. INTEGRATED CLINICAL EXPERIENCE WITH ONC201 IN PREVIOUSLY-TREATED H3 K27M-MUTANT GLIOMA PATIENTS. Society for NeuroOncology (SNO) 23th Annual Meeting and Education Day. https://doi.org/10.1093/neuonc/noy148.067

Chi, A, Arrillaga-Romany, I, Gardner, S, Wen, P, Batchelor, T, Hall, M , Odia, Y, Khatua, S, Zaky, W, McGovern, S, Harrison, R, de Groot, J, Sumrall, A, Shonka, N, Khatib, Z, Karajannis, M, Mueller, S, Tarapore, R, Merdinger, K, Schalop, L, Allen, J, Oster, W & Mehta, MP 2018, 'ACTR-34. INTEGRATED CLINICAL EXPERIENCE WITH ONC201 IN PREVIOUSLY-TREATED H3 K27M-MUTANT GLIOMA PATIENTS', Society for NeuroOncology (SNO) 23th Annual Meeting and Education Day, 11/5/18. https://doi.org/10.1093/neuonc/noy148.067

@conference{efafb12a60e949eda2f5b7b11ec15797,

title = "ACTR-34. INTEGRATED CLINICAL EXPERIENCE WITH ONC201 IN PREVIOUSLY-TREATED H3 K27M-MUTANT GLIOMA PATIENTS",

author = "Andrew Chi and Isabel Arrillaga-Romany and Sharon Gardner and Patrick Wen and Tracy Batchelor and Matthew Hall and Yazmin Odia and Soumen Khatua and Wafik Zaky and Susan McGovern and Rebecca Harrison and \{de Groot\}, John and Ashley Sumrall and Nicole Shonka and Zaid Khatib and Matthias Karajannis and Sabine Mueller and Rohinton Tarapore and Krystal Merdinger and Lee Schalop and Joshua Allen and Wolfgang Oster and Mehta, \{Minesh P\}",

note = "AbstractBACKGROUND. H3 K27M-mutant gliomas have a dismal clinical prognosis and no proven curative therapy. We report the updated clinical experience with ONC2; Society for NeuroOncology (SNO) 23th Annual Meeting and Education Day ; Conference date: 05-11-2018",

year = "2018",

month = nov,

day = "5",

doi = "10.1093/neuonc/noy148.067",

language = "American English",

}

TY - CONF

T1 - ACTR-34. INTEGRATED CLINICAL EXPERIENCE WITH ONC201 IN PREVIOUSLY-TREATED H3 K27M-MUTANT GLIOMA PATIENTS

AU - Chi, Andrew

AU - Arrillaga-Romany, Isabel

AU - Gardner, Sharon

AU - Wen, Patrick

AU - Batchelor, Tracy

AU - Hall, Matthew

AU - Odia, Yazmin

AU - Khatua, Soumen

AU - Zaky, Wafik

AU - McGovern, Susan

AU - Harrison, Rebecca

AU - de Groot, John

AU - Sumrall, Ashley

AU - Shonka, Nicole

AU - Khatib, Zaid

AU - Karajannis, Matthias

AU - Mueller, Sabine

AU - Tarapore, Rohinton

AU - Merdinger, Krystal

AU - Schalop, Lee

AU - Allen, Joshua

AU - Oster, Wolfgang

AU - Mehta, Minesh P

N1 - AbstractBACKGROUND. H3 K27M-mutant gliomas have a dismal clinical prognosis and no proven curative therapy. We report the updated clinical experience with ONC2

PY - 2018/11/5

Y1 - 2018/11/5

UR - https://academic.oup.com/neuro-oncology/article/20/suppl_6/vi19/5154134

U2 - 10.1093/neuonc/noy148.067

DO - 10.1093/neuonc/noy148.067

M3 - Presentation

T2 - Society for NeuroOncology (SNO) 23th Annual Meeting and Education Day

Y2 - 5 November 2018

ER -

ACTR-34. INTEGRATED CLINICAL EXPERIENCE WITH ONC201 IN PREVIOUSLY-TREATED H3 K27M-MUTANT GLIOMA PATIENTS

Conference

Disciplines

Access to Document

Other files and links

Cite this